US2009156796A1PendingUtilityA1

Metastatic colon cancer specific promoter and uses thereof

Assignee: CELL GENESYS INCPriority: Jul 22, 2002Filed: Jan 29, 2008Published: Jun 18, 2009
Est. expiryJul 22, 2022(expired)· nominal 20-yr term from priority
C12N 15/86A61K 48/00C12N 2830/008C12N 2830/85C12N 2710/10345C12N 2710/10343A61K 48/0058
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Colon cancer specific promoter sequences and adenovirus vehicles are provided. By providing for transcriptional initiating regulation dependent upon transcription factors that are only active in specific, limited cell types, virus replication will be restricted to the target cells. The modified adenovirus may be used as a vehicle for introducing new genetic capability, particularly associated with cytotoxicity for treating neoplasia.

Claims

exact text as granted — not AI-modified
1 . A colon cancer transcriptional regulatory element (TRE), wherein said TRE is specific for metastatic colon cancer cells. 
     
     
         2 . The TRE according to  claim 1 , wherein said TRE is a human TRE. 
     
     
         3 . The TRE according to  claim 2 , wherein said TRE is derived from a PRL-3 gene. 
     
     
         4 . The TRE according to  claim 3 , wherein said TRE is derived from a 0.6 kb region upstream of the translational start codon for the PRL-3 gene, presented herein as SEQ ID NO:1. 
     
     
         5 . The TRE according to  claim 3 , wherein said TRE is derived from a 1 kb region upstream of the translational start codon for the PRL-3 gene, presented herein as SEQ ID NO:2. 
     
     
         6 . The TRE according to  claim 3 , wherein said TRE has the sequence set forth in SEQ ID NO:1 or SEQ ID NO:2, or a functional fragment thereof. 
     
     
         7 - 21 . (canceled)

Join the waitlist — get patent alerts

Track US2009156796A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.